PillClindamycin Phosphate
Brands: Cleocin Phosphate · Clindamycin · Clindamycin Phosphate
5 active makers
soon
soon
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Pharmacia & Upjohn Company LLC | unknown | 7 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 7 | SUPPLYING |
| Sagent Pharmaceuticals | unknown | 3 | SUPPLYING |
| Henry Schein Inc. | unknown | 2 | SUPPLYING |
| ProPharma Distribution | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 21, 2023SHORTAGEDrug shortage: Clindamycin Phosphate Injection (Pfizer Inc.)
Clindamycin Phosphate Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Anti-Infective.
- Mar 21, 2023SHORTAGEDrug shortage: Clindamycin Phosphate Injection (Sagent Pharmaceuticals)
Clindamycin Phosphate Injection — reported in shortage by Sagent Pharmaceuticals. Therapeutic category: Anti-Infective.
- Mar 15, 2019RECALLRecall (Class III): Cleocin Phosphate, clindamycin injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vial, Rx only, Distributed by Pharmacia &…
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point — Recalling firm: Pfizer Inc. — Nationwide USA and Guam
- Mar 15, 2019RECALLRecall (Class III): Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by Pharmacia &…
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point — Recalling firm: Pfizer Inc. — Nationwide USA and Guam
- Mar 15, 2019RECALLRecall (Class III): Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by Pharmacia …
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point — Recalling firm: Pfizer Inc. — Nationwide USA and Guam
- Jun 4, 2013RECALLRecall (Class II): Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150 mg/mL) A…
Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial. — Recalling firm: Pharmacia & Upjohn LLC — Nationwide